Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04923776
Title Liver Directed RT + Chemo-immunotherapy for ES-SCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Brian Henick, MD
Indications

lung small cell carcinoma

Therapies

Atezolizumab + Carboplatin + Etoposide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.